Long-Term Outcomes of Trabeculectomy with Collagen Matrix Implant as a Bevacizumab Depot

The use of ologen implant as a drug depot for bevacizumab in trabeculectomy was safe and had a good long-term outcome.

Authors

Publication Details

Journal
Seminars in Ophthalmology
Published
2025-04-08
DOI
https://doi.org/10.1080/08820538.2025.2488888
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-Term Outcomes of Trabeculectomy with Collagen Matrix Implant as a Bevacizumab Depot

Parul Ichhpujani, Surinder Singh Pandav, Natasha Gautam, Sushmita Kaushik et al.
Seminars in Ophthalmology
Glaucoma and retinal disorders
article

Long-Term Outcomes of Trabeculectomy with Collagen Matrix Implant as a Bevacizumab Depot

Parul Ichhpujani, Surinder Singh Pandav, Natasha Gautam, Sushmita Kaushik, Srishti Raj, Faisal Thattaruthody
article en

Abstract

The use of ologen implant as a drug depot for bevacizumab in trabeculectomy was safe and had a good long-term outcome.

Seminars in OphthalmologyVol. 40(8)
Zero hunger
Openalex Percentile: Top 88%
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Long-Term Outcomes of Trabeculectomy with Collagen Matrix Implant as a Bevacizumab Depot — Parul Ichhpujani, Surinder Singh Pandav, et al. · Seminars in Ophthalmology (2025) | TGRS Research Map | TGRS